Previous research has shown that entinostat, a histone deacetylase inhibitor with the ability to prevent PAX3::FOXO1 transcription, is able to act in synergy with vincristine to prevent tumorigenesis in specific mouse models of ARMS (47). The gene discussed is FOXO1; the disease is alveolar rhabdomyosarcoma.